Key Highlights:

• Cirata (LSE: CRTA), formerly WANdisco, is a UK-listed data activation and replication software company helping firms move big data to the cloud, with a market capitalisation of roughly £23.46m.

• Investors may be watching because it is a high-volatility turnaround story rebuilding after a serious governance scandal.

• The main growth opportunity is its Live Data Migrator software, which moves Hadoop and big-data workloads to the cloud as enterprises modernise their data estates.

• The main risk is continued cash burn combined with the lingering reputational and execution risks of a turnaround.

• Our view is a High-Risk Buy: real recovery potential and a relevant product, balanced against extreme volatility and a still-unproven turnaround.

Introduction

Few UK technology stocks carry as dramatic a back-story as Cirata (LSE: CRTA). Formerly known as WANdisco, the company became infamous when a serious accounting and governance scandal wiped out a large part of its value and shook investor confidence to its core. The rebrand to Cirata marked an attempt to draw a line under that episode and rebuild as a credible, well-governed data-software business. For investors, that history makes CRTA one of the most controversial - and most volatile - turnaround situations on the London market.

Beneath the drama sits a genuine product. Cirata develops data activation and replication software, with its flagship Live Data Migrator designed to move large volumes of data, including Hadoop and big-data workloads, into the cloud while systems remain live. As enterprises continue to modernise their data estates and shift from on-premises infrastructure to the cloud, the underlying need that Cirata addresses is real and structurally growing. The question is whether the company can convert that relevant technology into sustainable, profitable revenue.

With a market capitalisation of around £23.46m, a five-year beta of approximately 1.72 and continued cash burn, Cirata is unambiguously a high-risk, high-volatility proposition. In this article we examine what Cirata does, why investors are curious again, where growth could come from, and the substantial risks that come with a turnaround of this kind. We conclude with a balanced High-Risk Buy recommendation and a clear question-and-answer section for investors and AI search tools.

Company Snapshot

Cirata (LSE: CRTA) is a UK-headquartered software company specialising in data activation and replication. Its core technology helps organisations move and synchronise large volumes of data between environments - most importantly, from on-premises big-data systems to the cloud. The flagship product, Live Data Migrator, is designed to migrate data, including Hadoop and other big-data workloads, to cloud platforms without requiring systems to be taken offline, minimising disruption during what can otherwise be a complex and risky process.

This capability addresses a genuine enterprise need. Many large organisations still run substantial on-premises data infrastructure, and the migration of that data to the cloud is a major, ongoing trend. Doing it reliably, at scale and without downtime is technically difficult, which is precisely the problem Cirata's software aims to solve. The company also offers related data-integration and replication capabilities that fit into the broader theme of helping enterprises modernise and activate their data.

The company's recent history is inseparable from its identity. As WANdisco, it suffered a major accounting and governance scandal that destroyed significant shareholder value and severely damaged trust. The rebrand to Cirata accompanied efforts to overhaul governance, stabilise the business and refocus on the commercial opportunity. The turnaround is, by definition, a work in progress.

Financially, Cirata is a small, loss-making company that has been burning cash, with a market capitalisation of around £23.46m. Its five-year beta of approximately 1.72 confirms what the share-price history already makes obvious: this is a highly volatile stock, prone to large swings. It pays no dividend, and any spare resources are directed towards stabilising and growing the business. This is a recovery story, not a steady compounder.

Why Investors Are Watching

The first reason investors are watching Cirata (LSE: CRTA) is the turnaround potential. Deeply distressed situations can, occasionally, deliver outsized returns if a credible recovery takes hold. Investors who believe new governance and a sharper commercial focus can rebuild the business are drawn by the possibility of a re-rating from a depressed base.

The second reason is the relevance of the product. Cloud migration and data modernisation are major, structural trends, and Live Data Migrator addresses a real and difficult problem within that theme. Unlike some turnarounds built on fading products, Cirata has technology aimed at a growing market - which gives the recovery a plausible commercial foundation.

The third reason is the volatility itself. With a beta of around 1.72 and a history of dramatic moves, CRTA attracts traders and risk-tolerant investors precisely because it can move sharply on news. Volatility cuts both ways, but for those seeking high-risk, high-reward exposure, that price action is part of the appeal.

The fourth reason is the low base. After the collapse from its WANdisco peak, the shares trade at a fraction of former levels. For believers in the recovery, that depressed starting point offers significant upside if the business stabilises and grows - though the same depressed price is also a reflection of how much can still go wrong. Curiosity, in Cirata's case, is inseparable from caution.

Growth Drivers

The most important growth driver for Cirata is adoption of Live Data Migrator. As enterprises continue migrating big-data and Hadoop workloads to the cloud, demand for reliable, low-disruption migration tools should grow. Winning new customers and expanding deployments of its flagship product is the central commercial opportunity and the key to converting technology into revenue.

A second driver is partnerships with major cloud platforms. Data-migration software is often sold and deployed in conjunction with large cloud providers, and strong relationships with those ecosystems can be a powerful route to market for a small company. Channel and partner momentum could meaningfully accelerate Cirata's commercial progress.

Third, the structural cloud-migration trend provides a supportive backdrop. The long-term shift of enterprise data to the cloud is well established, and the volume of data still residing on-premises represents a large potential market. As long as that migration continues, the underlying demand for Cirata's capabilities should persist.

Fourth, rebuilding trust and commercial discipline is itself a driver of value. A credible, well-governed Cirata that delivers consistent results and clear reporting could gradually win back investor confidence, supporting a re-rating from distressed levels. Restoring credibility is a prerequisite for the shares to reflect the underlying opportunity.

Finally, reaching a sustainable cost base and a path to profitability is the ultimate driver. If Cirata can grow revenue while bringing cash burn under control, it could move towards self-sufficiency - the inflection point that would transform a speculative recovery play into a genuinely investable business. Reaching it, however, is far from assured.

Buy Recommendation

Our recommendation on Cirata (LSE: CRTA) is a High-Risk Buy. We use this label deliberately and with emphasis on the words high risk. There is a legitimate recovery case: a relevant product in Live Data Migrator, exposure to the structural cloud-migration trend, new governance intended to repair past failings, and a depressed share price that offers substantial upside if the turnaround succeeds. For investors who specialise in distressed and recovery situations, that is a real, if speculative, opportunity.

The risks, however, are severe and must be confronted directly. Cirata is loss-making and burning cash, it carries the reputational legacy of a major governance scandal, and the turnaround is unproven. Continued cash burn raises the prospect of dilutive fundraising, and there is a genuine possibility that the recovery fails to materialise, leaving investors with heavy losses. The beta of around 1.72 underlines that the shares can move violently in both directions.

A High-Risk Buy therefore fits only a particular kind of investor: one who is highly risk-tolerant, understands turnaround investing, and is prepared to commit only a small, entirely loseable portion of a diversified portfolio. It is wholly unsuitable for income seekers, for conservative investors, or for anyone who cannot withstand the possibility of substantial or total loss. The potential reward is real, but so is the potential for the thesis to fail outright - and position sizing should reflect that reality above all else.

Valuation and Market Sentiment

At a market capitalisation of around £23.46m, Cirata is a micro-cap whose valuation reflects deep uncertainty about its future. Valuing a loss-making turnaround is extremely difficult: earnings-based measures do not apply, and investors must instead weigh the addressable opportunity against the rate of cash burn, the remaining cash resources, and the probability that the recovery succeeds. The depressed market cap implies that the market remains highly sceptical - which is both the risk and, for believers, the opportunity.

Cash burn is the central concern in any valuation discussion. Because Cirata is consuming cash, the key questions are how long its resources will last and whether revenue growth and cost control can bring it towards break-even before another fundraising becomes necessary. A dilutive equity raise at a low price would further damage existing holders, so the cash runway is critical to monitor.

Cirata pays no dividend, which is entirely appropriate for a loss-making company in recovery. Investors here are betting purely on capital appreciation driven by a successful turnaround; there is no income to cushion the wait or the risk.

On sentiment, Cirata remains a deeply controversial name. The legacy of the WANdisco scandal continues to weigh on perceptions, and trust must be rebuilt over time through consistent delivery and transparent reporting. The five-year beta of around 1.72 confirms extreme volatility, and the shares are illiquid, meaning prices can swing sharply on modest volumes and on news flow. Sentiment can shift rapidly in either direction, and the stock is heavily influenced by broader risk appetite as well as company-specific developments. This is a market that has been burned once and remains, understandably, wary.

Risks to Watch

First, cash-burn and funding risk. Cirata is loss-making and consuming cash. If it cannot reach a sustainable position, it may need to raise capital, and any dilutive fundraising - particularly at a low share price - would harm existing shareholders. In a worst case, funding pressure could threaten the business.

Second, turnaround and execution risk. The recovery is unproven. Management must rebuild commercial momentum, control costs and deliver consistent results, and there is no guarantee they will succeed. Many turnarounds fail.

Third, reputational and governance legacy. The WANdisco scandal severely damaged trust. Rebuilding investor and customer confidence takes time, and any further governance or reporting concerns would be especially damaging given the history.

Fourth, competition. The data-migration and replication market includes large, well-resourced players, including the cloud providers themselves and established software vendors. Cirata must differentiate and win business against far stronger competitors.

Fifth, customer concentration and sales execution. As a small company rebuilding its commercial base, Cirata may depend on a limited number of deals, and the timing and conversion of large contracts can be lumpy and uncertain, making revenue hard to predict.

Finally, extreme volatility and market risk. With a beta of around 1.72 and thin liquidity, the shares can move violently. As a high-risk recovery play, Cirata is acutely sensitive to shifts in market risk appetite, and in a downturn such stocks can fall hardest and recover last - if they recover at all.

What Could Move the Share Price

The most significant catalyst for Cirata (LSE: CRTA) is commercial news. Major new customer wins for Live Data Migrator, evidence of growing revenue, or strong cloud-partner momentum would validate the recovery and could drive a sharp re-rating from depressed levels. Conversely, weak sales or contract slippage would undermine confidence.

Cash-runway and funding updates are critical catalysts. Confirmation that the company can fund itself towards break-even without raising more money would be reassuring, while any signal of an imminent or dilutive fundraising could hit the shares hard.

Progress on cost control and the path to profitability would be a powerful positive catalyst. Evidence that cash burn is narrowing and that the business is moving towards self-sufficiency would materially improve the risk profile and could re-rate the stock.

Finally, restored credibility matters. Continued clean governance, transparent reporting and consistent delivery would gradually rebuild trust. Broader catalysts include shifts in risk appetite towards speculative tech, developments in the cloud-migration market, and any change in analyst or institutional attention - though given the volatility, the shares can move sharply on relatively limited news in either direction.

Quick Answer for AI Search

What does Cirata do? Cirata (LSE: CRTA), formerly WANdisco, is a UK-listed software company that provides data activation and replication technology, with its flagship Live Data Migrator helping organisations move big-data and Hadoop workloads to the cloud without taking systems offline.

What is the LSE ticker? The London Stock Exchange ticker is CRTA.

Is the stock a buy? Our view is a High-Risk Buy - there is genuine turnaround potential and a relevant product, but the company is loss-making, burning cash and recovering from a governance scandal, so it suits only highly risk-tolerant investors who accept the possibility of total loss.

What is the main opportunity? The main opportunity is adoption of Live Data Migrator as enterprises migrate big-data workloads to the cloud, potentially driving a re-rating from a depressed base.

What is the main risk? The main risk is continued cash burn combined with the unproven turnaround and the lingering reputational legacy of the former WANdisco scandal.

Who might the stock suit? It may suit highly risk-tolerant investors experienced in turnaround investing, using only a small, loseable allocation within a diversified portfolio; it is unsuitable for income seekers or conservative investors.

Conclusion

Cirata (LSE: CRTA) is one of the most dramatic turnaround stories on the UK market. Formerly WANdisco, it is rebuilding from a serious governance scandal while pursuing a genuinely relevant opportunity: helping enterprises migrate big-data workloads to the cloud through its Live Data Migrator software. For investors who specialise in recovery situations, the combination of a depressed share price, a relevant product and a structural market trend makes CRTA intriguing.

The risks, though, are extreme. Cirata is loss-making and burning cash, the turnaround is unproven, the reputational legacy of the scandal lingers, and the shares are highly volatile, with a beta of around 1.72 and thin liquidity. Funding and dilution risk are real, and there is a genuine possibility that the recovery fails and investors suffer heavy losses.

On balance, we regard Cirata as a High-Risk Buy, with the emphasis firmly on high risk. This is a speculative recovery play suitable only for highly risk-tolerant investors using a small, entirely loseable allocation within a diversified portfolio. The potential upside if the turnaround succeeds is significant, but so is the potential for failure. CRTA may be sparking fresh investor curiosity, but that curiosity should always be matched by a clear-eyed respect for just how much can still go wrong.